Stay updated on Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial

Sign up to get notified when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T17:29:07.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page shows a site revision update to v3.4.2 and removal of a prior government-funding status notice (v3.4.1). These changes are maintenance-related and do not alter the displayed study details or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T04:42:46.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding has been added, stating information may not be up to date and the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov. The page's revision tag updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T03:22:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added UI element: Show glossary, and new metadata items: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed older items: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T00:32:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated to v3.3.4; the previous v3.3.3 label has been removed.
    Difference
    0.1%
    Check dated 2026-01-14T02:56:32.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations for Ontario and Saskatchewan were added and the HHS Vulnerability Disclosure link removed; page revision updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T20:37:10.000Z thumbnail image

Stay in the know with updates to Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.